tiprankstipranks

Intra-Cellular downgraded to Hold from Buy at Needham

Needham analyst Ami Fadia downgraded Intra-Cellular (ITCI) to Hold from Buy without a price target after Johnson & Johnson said will acquire all outstanding shares of Intra-Cellular for a payment of $132.00 per share in cash.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1